Historical record - last NADAC publication: 3/18/2020
Product Information
PROPAFENONE HCL ER 425 MG CAP is a generic product labeled by Vitruvias Therapeutics Inc., priced at $3.6869 per EA under NDC 69680013260. Its NADAC has been published 103 times since Feb 20, 2019.
Strength
425 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680013260
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
3/18/2020
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210339On Market Since
1/28/2019
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL ER 425 MG CAP has been published 103 times since Feb 20, 2019, and over the history we have for it it has declined 35.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6869 per EA |
|---|---|
| All-time high | $5.6831 (Sep 11, 2019) |
| All-time low | $2.7880 (Oct 23, 2019) |
| Median price | $3.6869 |
| Average price | $4.0850 |
| Largest weekly change | -50.9% (Oct 23, 2019) |
| Weeks tracked | 103 |
| Tracking since | Feb 20, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the propafenone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL ER 425 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL ER 425 MG CAP, manufactured by Vitruvias Therapeutics Inc., is $3.6869 per EA (NDC 69680013260), effective Mar 10, 2021.
How has the price of PROPAFENONE HCL ER 425 MG CAP changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL ER 425 MG CAP has declined 35.1%. It has been tracked across 103 weekly CMS publications since Feb 20, 2019.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL ER 425 MG CAP?
Since Feb 20, 2019, the NADAC for PROPAFENONE HCL ER 425 MG CAP has ranged from a low of $2.7880 (Oct 23, 2019) to a high of $5.6831 (Sep 11, 2019), with a median of $3.6869 per EA.
Are there cheaper alternatives to PROPAFENONE HCL ER 425 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PROPAFENONE HCL ER 425 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures PROPAFENONE HCL ER 425 MG CAP?
PROPAFENONE HCL ER 425 MG CAP (NDC 69680013260) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification